{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:35:57Z","timestamp":1787315757947,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammatory bowel disease (IBD) is a persistent and chronic disease that is characterized by destructive gastrointestinal (GI) inflammation. Researchers are trying to identify and develop new and more effective treatments with no side effects. Acute and chronic mouse models of IBD were established using dextran sulfate sodium (DSS) solution. To evaluate the efficacy and mechanism, umbilical cord mesenchymal stem cells (UCMSCs) were obtained from Kunming (KM) mice and humans. In the chronic IBD study, the survival rates of the normal control, model, mouse UCMSC (mUCMSC) and human UCMSC (hUCMSC) groups were 100%, 40%, 86.7%, and 100%, respectively. The histopathological scores of the normal control, intraperitoneal injection, intravenous treatment, and model groups were 0.5\u2009\u00b1\u20090.30, 5.9\u2009\u00b1\u20091.10, 8.7\u2009\u00b1\u20091.39, and 8.8\u2009\u00b1\u20091.33 (p\u2009=\u20090.021). UCMSCs promoted the expression of the intestinal tight junction protein occludin, downregulated the protein expression of the autophagy marker LC3A\/B in colon tissue, and upregulated the expression of VEGF-A and VEGFR-1 at the injured site. This study provides an experimental model for elucidating the therapeutic effects of UCMSCs in IBD. We provide a theoretical basis and method for the clinical treatment of IBD using UCMSCs.<\/jats:p>","DOI":"10.1038\/s41598-019-54194-y","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T06:02:46Z","timestamp":1574834566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mechanism and therapeutic effect of umbilical cord mesenchymal stem cells in inflammatory bowel disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Xing-hua","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-an","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-min","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-qing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-ping","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"54194_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.imlet.2015.06.018","volume":"168","author":"M Algeri","year":"2015","unstructured":"Algeri, M. et al. Mesenchymal stromal cells and chronic inflammatory bowel disease. Immunol Lett. 168, 191\u2013200 (2015).","journal-title":"Immunol Lett."},{"key":"54194_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3892\/mmr.2014.2755","volume":"11","author":"Y Zhuang","year":"2015","unstructured":"Zhuang, Y. et al. Comparison of biological properties of umbilical cord-derived mesenchymal stem cells from early and late passages: immunomodulatory ability is enhanced in aged cells. Mol Med Rep. 11, 166\u2013174 (2015).","journal-title":"Mol Med Rep."},{"key":"54194_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1634\/stemcells.2005-0330","volume":"24","author":"ML Weiss","year":"2006","unstructured":"Weiss, M. L. et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson\u2019s disease. Stem Cells. 24, 781\u2013792 (2006).","journal-title":"Stem Cells."},{"key":"54194_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/mi.2016.78","volume":"10","author":"Y Qiu","year":"2017","unstructured":"Qiu, Y. et al. TLR3 preconditioning enhances the therapeutic efficacy of umbilical cord mesenchymal stem cells in TNBS-induced colitis via the TLR3-Jagged-1-Notch-1 pathway. Mucosal Immunol. 10, 727\u2013742 (2017).","journal-title":"Mucosal Immunol."},{"key":"54194_CR5","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3727\/096368910X557245","volume":"20","author":"L Liang","year":"2011","unstructured":"Liang, L. et al. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis. Cell Transplant. 20, 1395\u20131408 (2011).","journal-title":"Cell Transplant."},{"key":"54194_CR6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00535-005-1727-4","volume":"40","author":"A Andoh","year":"2005","unstructured":"Andoh, A. et al. Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response. J Gastroenterol. 40, 1089\u20131099 (2005).","journal-title":"J Gastroenterol."},{"key":"54194_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/path.1967","volume":"209","author":"S Bamba","year":"2006","unstructured":"Bamba, S. et al. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J Pathol. 209, 265\u2013273 (2006).","journal-title":"J Pathol."},{"key":"54194_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1053\/j.gastro.2006.12.029","volume":"132","author":"PN Khalil","year":"2007","unstructured":"Khalil, P. N. et al. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology. 132, 944\u2013954 (2007).","journal-title":"Gastroenterology."},{"key":"54194_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/gut.2008.168534","volume":"58","author":"E Gonzalez-Rey","year":"2009","unstructured":"Gonzalez-Rey, E. et al. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut. 58, 929\u2013939 (2009).","journal-title":"Gut."},{"key":"54194_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1053\/j.gastro.2015.03.013","volume":"149","author":"E Sala","year":"2015","unstructured":"Sala, E. et al. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine. Gastroenterology. 149, 163\u2013176 e120 (2015).","journal-title":"Gastroenterology."},{"key":"54194_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s10529-017-2315-4","volume":"39","author":"F Mao","year":"2017","unstructured":"Mao, F. et al. Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease through the regulation of 15-LOX-1 in macrophages. Biotechnol Lett. 39, 929\u2013938 (2017).","journal-title":"Biotechnol Lett."},{"key":"54194_CR12","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/gutjnl-2012-302152","volume":"62","author":"P Anderson","year":"2013","unstructured":"Anderson, P. et al. Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut. 62, 1131\u20131141 (2013).","journal-title":"Gut."},{"key":"54194_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09827-5","volume":"7","author":"JY Song","year":"2017","unstructured":"Song, J. Y. et al. Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages. Sci Rep. 7, 9412 (2017).","journal-title":"Sci Rep."},{"key":"54194_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13287-015-0073-6","volume":"6","author":"A Banerjee","year":"2015","unstructured":"Banerjee, A. et al. Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice. Stem Cell Res Ther. 6, 79 (2015).","journal-title":"Stem Cell Res Ther."},{"key":"54194_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum, J. A., Ong, J. F. & Karp, J. M. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 32, 252\u2013260 (2014).","journal-title":"Nat Biotechnol."},{"key":"54194_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/gut.2010.214841","volume":"60","author":"R Ciccocioppo","year":"2011","unstructured":"Ciccocioppo, R. et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn\u2019s disease. Gut. 60, 788\u2013798 (2011).","journal-title":"Gut."},{"key":"54194_CR17","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Panes","year":"2016","unstructured":"Panes, J. et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet. 388, 1281\u20131290 (2016).","journal-title":"Lancet."},{"key":"54194_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5009\/gnl17035","volume":"12","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn\u2019s Disease: A Randomized Controlled Clinical Trial. Gut Liver. 12, 73\u201378 (2018).","journal-title":"Gut Liver."},{"key":"54194_CR19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","volume":"136","author":"MA Gonzalez","year":"2009","unstructured":"Gonzalez, M. A. et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology. 136, 978\u2013989 (2009).","journal-title":"Gastroenterology."},{"key":"54194_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep30696","volume":"6","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis. Sci Rep. 6, 30696 (2016).","journal-title":"Sci Rep."},{"key":"54194_CR21","doi-asserted-by":"publisher","first-page":"e33360","DOI":"10.1371\/journal.pone.0033360","volume":"7","author":"MT Castelo-Branco","year":"2012","unstructured":"Castelo-Branco, M. T. et al. Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. PLoS One. 7, e33360 (2012).","journal-title":"PLoS One."},{"key":"54194_CR22","doi-asserted-by":"publisher","first-page":"18228","DOI":"10.3748\/wjg.v20.i48.18228","volume":"20","author":"C Goncalves Fda","year":"2014","unstructured":"Goncalves Fda, C. et al. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis? World J Gastroenterol. 20, 18228\u201318239 (2014).","journal-title":"World J Gastroenterol."},{"key":"54194_CR23","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/stem.1638","volume":"32","author":"F Yin","year":"2014","unstructured":"Yin, F. et al. Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses. Stem Cells. 32, 1278\u20131288 (2014).","journal-title":"Stem Cells."},{"key":"54194_CR24","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1136\/gut.2010.215152","volume":"59","author":"M Duijvestein","year":"2010","unstructured":"Duijvestein, M. et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn\u2019s disease: results of a phase I study. Gut. 59, 1662\u20131669 (2010).","journal-title":"Gut."},{"key":"54194_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12022-015-9362-y","volume":"26","author":"J Katuchova","year":"2015","unstructured":"Katuchova, J. et al. Mesenchymal stem cells in the treatment of type 1 diabetes mellitus. Endocr Pathol. 26, 95\u2013103 (2015).","journal-title":"Endocr Pathol."},{"key":"54194_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.299","volume":"5","author":"K Na","year":"2014","unstructured":"Na, K. et al. Bone marrow-derived clonal mesenchymal stem cells inhibit ovalbumin-induced atopic dermatitis. Cell Death Dis. 5, e1345 (2014).","journal-title":"Cell Death Dis."},{"key":"54194_CR27","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1002\/stem.1755","volume":"32","author":"JD Glenn","year":"2014","unstructured":"Glenn, J. D., Smith, M. D., Calabresi, P. A. & Whartenby, K. A. Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis. Stem Cells. 32, 2744\u20132755 (2014).","journal-title":"Stem Cells."},{"key":"54194_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.tice.2016.05.008","volume":"48","author":"A Muheremu","year":"2016","unstructured":"Muheremu, A., Peng, J. & Ao, Q. Stem cell based therapies for spinal cord injury. Tissue Cell. 48, 328\u2013333 (2016).","journal-title":"Tissue Cell."},{"key":"54194_CR29","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1053\/j.gastro.2010.11.047","volume":"140","author":"KH Jung","year":"2011","unstructured":"Jung, K. H. et al. Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology. 140, 998\u20131008 (2011).","journal-title":"Gastroenterology."},{"key":"54194_CR30","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/leu.2011.108","volume":"25","author":"M Krampera","year":"2011","unstructured":"Krampera, M. Mesenchymal stromal cell \u2018licensing\u2019: a multistep process. Leukemia. 25, 1408\u20131414 (2011).","journal-title":"Leukemia."},{"key":"54194_CR31","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1182\/blood-2010-12-324038","volume":"117","author":"D Mougiakakos","year":"2011","unstructured":"Mougiakakos, D. et al. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood. 117, 4826\u20134835 (2011).","journal-title":"Blood."},{"key":"54194_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.imlet.2007.04.001","volume":"110","author":"K English","year":"2007","unstructured":"English, K., Barry, F. P., Field-Corbett, C. P. & Mahon, B. P. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett. 110, 91\u2013100 (2007).","journal-title":"Immunol Lett."},{"key":"54194_CR33","doi-asserted-by":"publisher","first-page":"e101558","DOI":"10.1371\/journal.pone.0101558","volume":"9","author":"SH Hwang","year":"2014","unstructured":"Hwang, S. H. et al. Toll like receptor 3 & 4 responses of human turbinate derived mesenchymal stem cells: stimulation by double stranded RNA and lipopolysaccharide. PLoS One. 9, e101558 (2014).","journal-title":"PLoS One."},{"key":"54194_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0163-7258(91)90034-J","volume":"52","author":"F Arnold","year":"1991","unstructured":"Arnold, F. & West, D. C. Angiogenesis in wound healing. Pharmacol Ther. 52, 407\u2013422 (1991).","journal-title":"Pharmacol Ther."},{"key":"54194_CR35","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.jaci.2017.08.017","volume":"141","author":"X Li","year":"2018","unstructured":"Li, X. et al. Mesenchymal stem cells alleviate oxidative stress-induced mitochondrial dysfunction in the airways. J Allergy Clin Immunol. 141, 1634\u20131645 e1635 (2018).","journal-title":"J Allergy Clin Immunol."},{"key":"54194_CR36","doi-asserted-by":"publisher","first-page":"15007","DOI":"10.1038\/cddiscovery.2015.7","volume":"1","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Rap1-mediated nuclear factor-kappaB (NF-kappaB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarction. Cell Death Discov. 1, 15007 (2015).","journal-title":"Cell Death Discov."},{"key":"54194_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13287-019-1183-3","volume":"10","author":"S Liao","year":"2019","unstructured":"Liao, S. et al. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure. Stem Cell Res Ther. 10, 78 (2019).","journal-title":"Stem Cell Res Ther."},{"key":"54194_CR38","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3109\/14653249.2011.574118","volume":"13","author":"SP Chin","year":"2011","unstructured":"Chin, S. P. et al. Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy. Cytotherapy. 13, 814\u2013821 (2011).","journal-title":"Cytotherapy."},{"key":"54194_CR39","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1002\/stem.2094","volume":"33","author":"YQ Sun","year":"2015","unstructured":"Sun, Y. Q. et al. Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-gamma-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice. Stem Cells. 33, 3452\u20133467 (2015).","journal-title":"Stem Cells."},{"key":"54194_CR40","first-page":"74","volume":"356","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Absence of NUCKS augments paracrine effects of mesenchymal stem cells-mediated cardiac protection. Exp Cell Res. 356, 74\u201384 (2017).","journal-title":"Exp Cell Res."},{"key":"54194_CR41","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.stemcr.2018.09.012","volume":"11","author":"Y Yao","year":"2018","unstructured":"Yao, Y. et al. Connexin 43-Mediated Mitochondrial Transfer of iPSC-MSCs Alleviates Asthma Inflammation. Stem Cell Reports. 11, 1120\u20131135 (2018).","journal-title":"Stem Cell Reports."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54194-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54194-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54194-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:37:35Z","timestamp":1671277055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54194-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54194"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54194-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17646"}}